EG12280A - Process for preparing neue 6-aryl-s-triazolo-(4,3-a)pyrido-(2,3-f)-1,4-diazepine - Google Patents

Process for preparing neue 6-aryl-s-triazolo-(4,3-a)pyrido-(2,3-f)-1,4-diazepine

Info

Publication number
EG12280A
EG12280A EG76673A EG67376A EG12280A EG 12280 A EG12280 A EG 12280A EG 76673 A EG76673 A EG 76673A EG 67376 A EG67376 A EG 67376A EG 12280 A EG12280 A EG 12280A
Authority
EG
Egypt
Prior art keywords
neue
diazepine
triazolo
pyrido
aryl
Prior art date
Application number
EG76673A
Other languages
English (en)
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Application granted granted Critical
Publication of EG12280A publication Critical patent/EG12280A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
EG76673A 1975-11-04 1976-11-02 Process for preparing neue 6-aryl-s-triazolo-(4,3-a)pyrido-(2,3-f)-1,4-diazepine EG12280A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT837275A AT350056B (de) 1975-11-04 1975-11-04 Verfahren zur herstellung von neuen pyrido- (2,3-f)-(1,4)-diazepinen, deren optischen isomeren und salzen

Publications (1)

Publication Number Publication Date
EG12280A true EG12280A (en) 1978-12-31

Family

ID=3604891

Family Applications (1)

Application Number Title Priority Date Filing Date
EG76673A EG12280A (en) 1975-11-04 1976-11-02 Process for preparing neue 6-aryl-s-triazolo-(4,3-a)pyrido-(2,3-f)-1,4-diazepine

Country Status (30)

Country Link
US (1) US4110455A (no)
JP (1) JPS5831351B2 (no)
AR (3) AR217814A1 (no)
AT (1) AT350056B (no)
AU (1) AU504228B2 (no)
BE (1) BE847952A (no)
CA (1) CA1076111A (no)
CH (1) CH630920A5 (no)
CS (1) CS191181B2 (no)
DD (1) DD128178A5 (no)
DE (1) DE2649116A1 (no)
DK (1) DK142324B (no)
EG (1) EG12280A (no)
ES (2) ES452971A1 (no)
FI (1) FI62088C (no)
FR (1) FR2330404A1 (no)
GB (1) GB1562800A (no)
HU (1) HU177422B (no)
IL (1) IL50816A (no)
IN (1) IN144289B (no)
MX (1) MX4284E (no)
NL (1) NL7612187A (no)
NO (1) NO146470C (no)
PL (2) PL118308B1 (no)
PT (1) PT65787B (no)
RO (2) RO77294A (no)
SE (1) SE7612260L (no)
SU (2) SU667137A3 (no)
YU (1) YU269176A (no)
ZA (1) ZA766620B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1185601A (en) * 1981-02-27 1985-04-16 Walter Hunkeler Imidazodiazepines
DE3435973A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
US8541407B2 (en) 2010-03-31 2013-09-24 Arqule, Inc. Substituted benzo-pyrido-triazolo-diazepine compounds
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
US9249161B2 (en) 2010-12-02 2016-02-02 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2705039B1 (en) 2011-05-04 2017-07-26 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2721031B1 (en) 2011-06-17 2016-01-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2013184878A1 (en) 2012-06-06 2013-12-12 Constellation Pharmaceuticals, Inc. Benzo [b] isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
DK3157928T3 (da) 2014-06-20 2019-05-20 Constellation Pharmaceuticals Inc Krystallinske former af 2-((4s)-6-(4-chlorphenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT327917B (de) * 1973-04-12 1976-02-25 Degussa Verfahren zur herstellung von neuen 5-aryl-pyrido- (b-6,7) -1,4-diazepinen und deren salzen
US4039551A (en) * 1976-03-15 1977-08-02 The Upjohn Company 1-[(Hydroxyamino)methyl]-6-aryl-4H-s-triazolo[4,3-a][1,4]benzodiazepines

Also Published As

Publication number Publication date
PL113803B1 (en) 1981-01-31
NO763739L (no) 1977-05-05
JPS5259194A (en) 1977-05-16
ATA837275A (de) 1978-10-15
RO70245A (ro) 1981-06-30
AR216915A1 (es) 1980-02-15
CH630920A5 (de) 1982-07-15
RO77294A (ro) 1982-09-09
BE847952A (fr) 1977-05-03
IL50816A0 (en) 1977-01-31
ES452971A1 (es) 1978-10-16
NO146470B (no) 1982-06-28
PL193439A1 (pl) 1979-07-16
AR217814A1 (es) 1980-04-30
FR2330404B1 (no) 1979-07-20
FI763158A (no) 1977-05-05
IN144289B (no) 1978-04-22
AU1931176A (en) 1978-05-11
YU269176A (en) 1983-02-28
DK142324B (da) 1980-10-13
SU676165A3 (ru) 1979-07-25
ES452969A1 (es) 1977-11-16
DE2649116A1 (de) 1977-05-18
FR2330404A1 (fr) 1977-06-03
FI62088C (fi) 1982-11-10
AT350056B (de) 1979-05-10
NO146470C (no) 1982-10-06
PL118308B1 (en) 1981-09-30
DK497076A (no) 1977-05-05
CA1076111A (en) 1980-04-22
DK142324C (no) 1981-03-02
SE7612260L (sv) 1977-05-05
AU504228B2 (en) 1979-10-04
JPS5831351B2 (ja) 1983-07-05
US4110455A (en) 1978-08-29
FI62088B (fi) 1982-07-30
MX4284E (es) 1982-03-12
SU667137A3 (ru) 1979-06-05
PT65787B (de) 1978-05-10
PT65787A (de) 1976-12-01
HU177422B (en) 1981-10-28
IL50816A (en) 1980-09-16
CS191181B2 (en) 1979-06-29
DD128178A5 (de) 1977-11-02
AR216916A1 (es) 1980-02-15
NL7612187A (nl) 1977-05-06
ZA766620B (en) 1977-12-28
GB1562800A (en) 1980-03-19

Similar Documents

Publication Publication Date Title
HU177914B (en) Process for preparing 21-phenyl-sulphinyl-pregna-4,17/20/,20-trien-3-ones
YU39342B (en) Process for obtaining 1,2,3-thiadiazolyl-carbamides
EG12280A (en) Process for preparing neue 6-aryl-s-triazolo-(4,3-a)pyrido-(2,3-f)-1,4-diazepine
YU146285A (en) Process for making 3',4'-dideoxicanamycine b
AU1710176A (en) 3-phenylspiro(isobenzofuran-1,4'-piperidine)-sulfenamides andderivatives
CS189007B2 (en) Process for preparing 2/methoxybenzamides
YU39481B (en) Process for the manufacture of 1-alkyl-1-(beta-alkoxycarboethyl)-1,2,3,4,6,7,12,12b-octahydroindolo(2,3-a)-quinolizine
CS191998B2 (en) Process for preparing 3,7-dimethyl-2-octennitrile
JPS5283309A (en) Process for preparing 1*11dihaloo44methyll1*33pentadiene
JPS5214705A (en) Process for preparing 22chlorobutadienee1*3
HU174502B (hu) Sposob poluchenija novykh proizvodnykh oktagidro-indolo/2,3-a/-khinolizina
YU258476A (en) Process for preparing 2,9-dioxa-triyclo-4,3,1,0,3,7,-decanes
JPS51138634A (en) Process for preparing 2*55dimethoxyy44 chloroaniline
JPS51143637A (en) Process for preparing 3*55diitertt butyll44hydroxybenzaldehyde
GB1545521A (en) 10-substituted-4h-benzo(4,5)cyclohepta(1,2-b)-thiophens
JPS5251304A (en) Process for preparing 1*11difluoroethane
JPS51131840A (en) Process for preparing nnacetoacetyll2*55 dimethoxyy44chloroanilide
JPS51143602A (en) Process for preparing 1*11dihaloo1*33diene
JPS51136604A (en) Process for preparing 1*11dichloroo44methylpentaa1*33diene
YU42626B (en) Process for making 3',4'-dideoxykanamycine b
JPS5210264A (en) 1*33dihydroo33phenyll1***22 propynyl* spiro *isobenzofurane*
JPS51150846A (en) Forming machine for underdrain
JPS527907A (en) Process for preparing 1*11dihaloo44methylpentadiene
YU175376A (en) Process for preparing substituted 6-aryl-4h-s-triazolo-(3,4-c)-thieno-(2,3-e)-1,4-diazepines
CS192554B2 (en) Process for preparing 3,5-diphenylpyrazolones